Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

SAGE Therapeutics (SAGE) Misses Q2 EPS by 14c

August 3, 2021 6:40 AM EDT

SAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($1.83), $0.14 worse than the analyst estimate of ($1.69). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.01 million.

Announced positive topline data from pivotal WATERFALL Study of zuranolone in patients with MDD showing... More